Instytut Gruzlicy i Chorob Pluc

Instytut Gruzlicy i Chorob Pluc is a research organisation in Warszawa, Poland that has taken part in 12 EU-funded projects since 2008, receiving €2.6M in EU funding.

EU funding received€2.6M
EU projects12
As coordinator0
Running now5
First EU project2008
Latest project2026
CountryPoland
EU registration (PIC)998888250
On this page · 5 sections→

Where the EU money came from

Funding by EU programme. Amounts are Instytut Gruzlicy i Chorob Pluc's own share of each project, not the project's full budget.

  • EU4Health Programme (EU4H)€1.8M · 6 projects
  • Horizon 2020€488k · 2 projects
  • FP7 (2007 to 2013)€230k · 3 projects
  • Interregional Innovation Investments Instrument (I3)€97k · 1 project

Projects

12 EU-funded projects, newest first. Each links to the official record.

  • SOLACE PlusPartner

    Strengthening the Screening of Lung Cancer in Europe – Pilots, Learning, Uptake and Sustainability

    EU4Health Programme (EU4H) · 2026–2029 · Project on the EU portal ↗

    €120ktheir share
  • SPARCPartner

    Support of Personalized medicine Approaches in Cancer

    EU4Health Programme (EU4H) · 2025–2028 · Project on the EU portal ↗

    €208ktheir share
  • JANE-2Associated partner

    Joint Action on Networks of Expertise on Cancer

    EU4Health Programme (EU4H) · 2024–2028 · Project on the EU portal ↗

    €232ktheir share
  • EUnetCCC JAAssociated partner

    The European Comprehensive Cancer Centre Network

    EU4Health Programme (EU4H) · 2024–2028 · Project on the EU portal ↗

    €257ktheir share
  • EUCanScreenAssociated partner

    Implementation of cancer screening programmes.

    EU4Health Programme (EU4H) · 2024–2028 · Project on the EU portal ↗

    €17ktheir share
  • DigiONE I3Partner

    DIGItal Infrastructure for ONcology in Europe

    Interregional Innovation Investments Instrument (I3) · 2023–2026 · Project on the EU portal ↗

    €97ktheir share
  • SOLACEPartner

    Strengthening the screening of Lung Cancer in Europe

    EU4Health Programme (EU4H) · 2023–2026 · Project on the EU portal ↗

    €949ktheir share
  • SLEEP REVOLUTIONPartner

    Revolution of sleep diagnostics and personalized health care based on digital diagnostics and therapeutics with health data integration

    Horizon 2020 · 2021–2025 · Project on CORDIS ↗

    €123ktheir share
  • TETRAPartner

    Autologous Stem Cell Seeded Tissue Engineered Trachea

    Horizon 2020 · 2016–2019 · Project on CORDIS ↗

    €365ktheir share
  • AirPROMPartner

    Airway Disease PRedicting Outcomes through Patient Specific Computational Modelling

    FP7 (2007 to 2013) · 2011–2016 · Project on CORDIS ↗

    €36ktheir share
  • TB PAN-NETPartner

    Pan-European network for the study and clinical management of drug resistant tuberculosis

    FP7 (2007 to 2013) · 2009–2014 · Project on CORDIS ↗

    €46ktheir share
  • EVAPartner

    Markers for emphysema versus airway disease in COPD

    FP7 (2007 to 2013) · 2008–2012 · Project on CORDIS ↗

    €148ktheir share

Works most with

Organisations that shared the most EU projects with this one. A good starting list for consortium partners.

Fields it works in

Research fields recorded on its Horizon projects.

  • DNA
  • RNA
  • asthma
  • data protection
  • data science
  • drug resistance
  • epidemiology
  • hepatology
  • mortality
  • nongovernmental organizations
  • pathology
  • physiology
  • proteins
  • radiology

Is this your organisation?

Claim it with an EUACC listing (€39 once, reviewed by our editors): add what you build, your team and what you are looking for. We pre-fill it from your EU records. Listed companies reach investors through our newsletter and get matched to new EU calls first.

Claim this profile →

Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships. Official website ↗

Europe’s tech funding.
One place.

The weekly briefing

Funding calls, VC news and key deadlines — a weekly briefing for European founders.

Free · unsubscribe anytime